IBKS No3 SPAC Cash Flow Conversion Efficiency

Latest as of June 2026: -0.003x

IBKS No3 SPAC cash flow conversion efficiency. Based on the latest financial reports, IBKS No3 SPAC (225430) has a cash flow conversion efficiency ratio of -0.003x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-79.11 Million ≈ $-53.61K USD) by net assets (₩26.67 Billion ≈ $18.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of IBKS No3 SPAC (2016–2025)

Cash flow conversion efficiency of IBKS No3 SPAC from 2016 to 2025. This chart illustrates how IBKS No3 SPAC's cash flow conversion efficiency has evolved over time, based on yearly financial data. View IBKS No3 SPAC stock price for real-time trading data and today's change.

IBKS No3 SPAC Cash Flow Conversion Ratio Explained

IBKS No3 SPAC cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

IBKS No3 SPAC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of IBKS No3 SPAC ranked by their cash flow conversion efficiency. Also see IBKS No3 SPAC market cap and net worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Great Atlantic Resources Corp
V:GR
0.014x
Pheton Holdings Ltd Class A Ordinary Shares
NASDAQ:PTHL
-0.599x
Evogene
TA:EVGN
-0.220x
Sylvania Platinum Limited
LSE:SLP
0.095x
Mid Wynd International Investment Trust plc
LSE:MWY
0.002x
Constellation Technologies Ltd
AU:CT1
0.038x
Sparton Resources Inc
V:SRI
-0.143x
MMC Sanayi ve Ticari Yatirimlar AS
IS:MMCAS
0.001x

Annual Cash Flow Conversion Efficiency for IBKS No3 SPAC (2016–2025)

The table below shows the annual cash flow conversion efficiency of IBKS No3 SPAC from 2016 to 2025. Review 225430 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩28.27 Billion
≈ $19.16 Million
₩-1.75 Billion
≈ $-1.19 Million
-0.062x +0.76%
2024-12-31 ₩32.62 Billion
≈ $22.10 Million
₩-2.04 Billion
≈ $-1.38 Million
-0.062x -253.12%
2023-12-31 ₩35.48 Billion
≈ $24.04 Million
₩1.45 Billion
≈ $980.06K
0.041x +1686.79%
2022-12-31 ₩36.33 Billion
≈ $24.62 Million
₩-93.32 Million
≈ $-63.24K
-0.003x -104.52%
2021-12-31 ₩39.91 Billion
≈ $27.04 Million
₩2.27 Billion
≈ $1.54 Million
0.057x +154.79%
2020-12-31 ₩40.77 Billion
≈ $27.63 Million
₩909.18 Million
≈ $616.14K
0.022x +176.93%
2019-12-31 ₩24.19 Billion
≈ $16.40 Million
₩-701.24 Million
≈ $-475.22K
-0.029x -156.77%
2018-12-31 ₩23.83 Billion
≈ $16.15 Million
₩1.22 Billion
≈ $824.56K
0.051x +1058.34%
2017-12-31 ₩8.48 Billion
≈ $5.74 Million
₩-45.15 Million
≈ $-30.60K
-0.005x +35.53%
2016-12-31 ₩8.46 Billion
≈ $5.73 Million
₩-69.90 Million
≈ $-47.37K
-0.008x --

About IBKS No3 SPAC

KQ:225430 Korea Asset Management
Market Cap
$2.64 Million
₩3.89 Billion KRW
Market Cap Rank
#29675 Global
#2091 in Korea
Share Price
₩698.00
Change (1 day)
+2.35%
52-Week Range
₩340.00 - ₩3035.00
All Time High
₩4900.00
About

KMPHARMACEUTICAL Co.,Ltd. engages in the manufacture, wholesale, and retail of oral care, beauty care, and other daily necessities in South Korea and internationally. The company offers toothpastes, toothbrushes, cosmetics, masks, hand cream, toothbrush and toothpaste, kids toothbrush, and baby finger toothbrush sets. It also provides children's safety gargles, baby and light wipes, wet wipes, an… Read more